Prediction of Childhood Epilepsy Outcome in Bangladesh

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00381537

Enrollment

Registered

2006-09-28

Start date

Unknown

Completion date

Unknown

Last updated

2006-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

childhood epilepsy, Active childhood epilepsy

Brief summary

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Interventions

DRUGphenobarbitone

DRUGcarbamazepine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

2 Years to 16 Years

Healthy volunteers

Inclusion criteria

* Active epilepsy * Aged 2-15 years

Exclusion criteria

* Excluded absence * Myoclonic and malignant epilepsy syndromes * Major motor and cognitive impairments * Those currently receiving antiepilepsy drugs.

Countries

Bangladesh, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026